A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Summary

The purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus erythematosus (SLE, a long-term disease where the immune system mistakenly attacks its own healthy tissues, causing swelling and redness in various organs).

Timeline

Start

2026-03-05

Primary completion

2028-12-06

Completion

2031-11-07

Drugs

Indications